Attached files

file filename
10-K - 10-K - AMAG PHARMACEUTICALS, INC.a2223053z10-k.htm
EX-21.1 - EX-21.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-21_1.htm
EX-32.1 - EX-32.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-32_1.htm
EX-31.1 - EX-31.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-31_1.htm
EX-10.6 - EX-10.6 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_6.htm
EX-31.2 - EX-31.2 - AMAG PHARMACEUTICALS, INC.a2223053zex-31_2.htm
EX-10.19 - EX-10.19 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_19.htm
EX-10.31 - EX-10.31 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_31.htm
EX-10.32 - EX-10.32 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_32.htm
EXCEL - IDEA: XBRL DOCUMENT - AMAG PHARMACEUTICALS, INC.Financial_Report.xls
EX-32.2 - EX-32.2 - AMAG PHARMACEUTICALS, INC.a2223053zex-32_2.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We hereby consent to the incorporation by reference in the Registration Statement on Forms S-3 (File Nos. 333-192132 and 333-202009) and S-8 (File Nos. 333-82292, 333-131656, 333-148682, 333-159938, 333-168786, 333-182821, 333-190435 and 333-197873) of AMAG Pharmaceuticals, Inc. of our report dated February 17, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PRICEWATERHOUSECOOPERS LLP

Boston, Massachusetts
February 17, 2015
   



QuickLinks

Consent of Independent Registered Public Accounting Firm